• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hepatic dearterialization for nonrespectable primary and secondary tumors of the liver.

作者信息

Nagasue N, Inokuchi K, Kobayashi M, Ogawa Y, Iwaki A

出版信息

Cancer. 1976 Dec;38(6):2593-603. doi: 10.1002/1097-0142(197612)38:6<2593::aid-cncr2820380654>3.0.co;2-6.

DOI:10.1002/1097-0142(197612)38:6<2593::aid-cncr2820380654>3.0.co;2-6
PMID:63320
Abstract

Seventeen patients with primary or secondary liver tumors were treated by dearterialization of the liver and intraportal infusion of cytotoxic drugs. In 14 cases, ligation of the main (10), right and left (1), right and middle (1), and right (2) hepatic arteries was performed. In three in whom hepatic artery ligation was considered to be contraindicated due to occlusion of the portal vein, temporary occlusion of the hepatic artery was repeated postoperatively. Only one patient died from the cause related to the ligation. Out of 14 patients who survived for more than one month ten showed an apparent regression of tumors radiologically. The mean survival period of the patients excluding those who died from other unrelated causes was 28 weeks. That of the control patients who received only chemotherapy through the hepatic artery was 13 weeks. The results were not always satisfactory, but dearterialization of the liver can be a palliative treatment for nonresectable liver tumors with a forceful combined chemotherapy.

摘要

相似文献

1
Hepatic dearterialization for nonrespectable primary and secondary tumors of the liver.
Cancer. 1976 Dec;38(6):2593-603. doi: 10.1002/1097-0142(197612)38:6<2593::aid-cncr2820380654>3.0.co;2-6.
2
Hemangiosarcoma of liver and spleen treated by hepatic artery ligation, intraportal infusion chemotherapy, and splenectomy.肝动脉结扎、门静脉内灌注化疗及脾切除术治疗肝脾血管肉瘤
Cancer. 1976 Sep;38(3):1386-90. doi: 10.1002/1097-0142(197609)38:3<1386::aid-cncr2820380343>3.0.co;2-1.
3
Results of liver dearterialization combined with regional infusion of 5-fluorouracil for liver cancer.肝癌肝去动脉化联合5-氟尿嘧啶区域灌注的结果
Acta Chir Scand. 1976;142(2):131-8.
4
Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer.
Ann Chir Gynaecol Suppl. 1976;65(1):27-32.
5
Hepatic artery ligation and infusion chemotherapy for malignancy of the liver.
J Am Med Womens Assoc (1972). 1979 Jan;34(1):21-6, 31-9.
6
Complete devascularization of hepatic lobe with nonresectable hepatoma.对伴有不可切除肝癌的肝叶进行完全去血管化。
Am J Surg. 1977 Nov;134(5):650-5. doi: 10.1016/0002-9610(77)90456-1.
7
Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma.
Am J Surg. 1976 Aug;132(2):236-42. doi: 10.1016/0002-9610(76)90054-4.
8
[A comparative assessment of the effectiveness of dearterialization of the liver and intraorgan chemotherapy in patients with liver cancer].[肝癌患者肝脏去动脉化与肝内化疗有效性的比较评估]
Vestn Khir Im I I Grek. 1998;157(1):28-31.
9
Selective ligation of portal vein and hepatic artery for ruptured hepatocellular carcinoma in a 13-year-old boy.选择性结扎门静脉和肝固有动脉治疗 13 岁男孩破裂的肝细胞癌。
J Pediatr Surg. 2011 May;46(5):973-7. doi: 10.1016/j.jpedsurg.2011.01.016.
10
Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors.短暂性肝动脉去血管化继以区域动脉内输注5-氟尿嘧啶作为肝肿瘤的治疗方法。
Ann Surg. 1981 Jan;193(1):82-8. doi: 10.1097/00000658-198101000-00014.

引用本文的文献

1
Experimental studies on the treatment of nonresectable liver cancer.
Jpn J Surg. 1981 Jan;11(1):58-65. doi: 10.1007/BF02468822.
2
Temporary liver dearterialization in patients with metastatic carcinoid disease.转移性类癌病患者的临时性肝去动脉化
World J Surg. 1982 Jan;6(1):46-53. doi: 10.1007/BF01656372.
3
Changes of hepatic function after hepatic artery ligation.
Acta Acad Med Wuhan. 1983;3(3):185-9. doi: 10.1007/BF02856657.
4
Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.
表柔比星动脉内给药治疗不可切除肝细胞癌。肝细胞癌表柔比星研究组。
Cancer Chemother Pharmacol. 1987;19(3):183-9. doi: 10.1007/BF00252970.
5
Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.不可切除肝细胞癌的治疗:一项随机对照试验的结果
World J Surg. 1986 Jun;10(3):501-9. doi: 10.1007/BF01655321.
6
Spontaneous remission of hepatocellular carcinoma after massive gastrointestinal haemorrhage.大量胃肠道出血后肝细胞癌的自发缓解
BMJ. 1990 Mar 10;300(6725):641-2. doi: 10.1136/bmj.300.6725.641.
7
Gas-forming intrahepatic abscess: a possible complication of arterial infusion chemotherapy.
Gastrointest Radiol. 1979 Apr 15;4(2):157-61. doi: 10.1007/BF01887516.
8
Remnant liver function during surgery for extensive hepatic resection.广泛肝切除术中的残余肝功能。
Jpn J Surg. 1979 Jun;9(2):125-31. doi: 10.1007/BF02468847.
9
Tumor embolism in the right atrium after hepatic artery ligation for hepatoma.肝癌肝动脉结扎术后右心房肿瘤栓塞
Jpn J Surg. 1977 Dec;7(4):246-52. doi: 10.1007/BF02469357.